Spruce BiosciencesSPRB
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 30 institutions reported holding Spruce Biosciences Inc. (SPRB) in their 13F filings, down 8 from Q2 2024. 0 opened new positions and 8 sold out. The largest holders were RiverVest Venture Management LLC ($1.4M), Carlyle Group Inc. ($1.3M) and Rock Springs Capital Management LP ($1.2M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Spruce Biosciences Inc.
- CUSIP
- 85209E109
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 8 | $1.5M |
All 13F filers, Q2 2024 → Q3 2024: 378,583 shares bought and 3,353,503 shares sold, net −2,974,920 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| RiverVest Venture Management LLC | 20.39% | No change | 2,936,281 | $1.4M |
| Carlyle Group Inc. | 0.14% | No change | 2,896,518 | $1.3M |
| Rock Springs Capital Management LP | 0.04% | No change | 2,609,125 | $1.2M |
| Acadian Asset Management LLC | 0.00% | Reduce -8.0% | 1,259,151 | $597K |
| Vanguard Group Inc. | 0.00% | Reduce -2.3% | 843,844 | $401K |
| Sands Capital Alternatives, LLC | 0.10% | No change | 787,007 | $370K |
| Renaissance Technologies | 0.00% | Add +66.5% | 609,700 | $290K |
| ADAR1 Capital Management, LLC | 0.03% | Add +13.7% | 403,716 | $192K |
| Almitas Capital LLC | 0.07% | No change | 396,506 | $188K |
| Geode Capital Management, LLC | 0.00% | Add +28.4% | 261,948 | $124K |
| BlackRock, Inc. | 0.00% | — | 124,734 | $59K |
| Citadel Advisors | 0.00% | Reduce -9.0% | 77,053 | $37K |
| Lion Point Capital, LP | 0.14% | No change | 75,000 | $36K |
| Northern Trust Corp. | 0.00% | No change | 74,927 | $36K |
| State Street Corp. | 0.00% | No change | 64,400 | $31K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -52.9% | 40,000 | $19K |
| Shay Capital LLC | 0.01% | Add +189.4% | 38,119 | $18K |
| Two Sigma Advisers, LP | 0.00% | Reduce -40.7% | 27,100 | $13K |
| Two Sigma Investments, LP | 0.00% | Reduce -18.3% | 23,368 | $11K |
| XTX Topco Ltd | 0.00% | Reduce -29.6% | 19,134 | $9K |
| Jane Street Group, LLC | 0.00% | Reduce -49.2% | 15,658 | $7K |
| Marex Group Ltd | 0.00% | No change | 14,800 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -86.0% | 4,650 | $2K |
| Royal Bank of Canada | 0.00% | Add +1628.2% | 3,733 | $2K |
| Group One Trading LLC | 0.00% | No change | 3,839 | $2K |
| Morgan Stanley | 0.00% | No change | 2,133 | $1K |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 1,000 | $475 |
| Bank of America Corp. | 0.00% | Add +48.7% | 223 | $106 |
| JPMorgan Chase & Co. | 0.00% | Reduce -1.4% | 71 | $33 |
| UBS Group AG | 0.00% | Reduce -100.0% | 13 | $6 |
"% of holder's portfolio" is SPRB's weight in each manager's 13F, not the share of Spruce Biosciences Inc. the manager owns.